104 related articles for article (PubMed ID: 10048939)
1. An assessment of future training needs for PhD graduates for European pharmaceutical companies: a report from the committee on industrial relations (CIR) of EUFEPS. European Federation for Pharmaceutical Sciences.
Eur J Pharm Sci; 1999 Feb; 7(3):iii-v. PubMed ID: 10048939
[No Abstract] [Full Text] [Related]
2. Network on veterinary medicines initiated by the European Federation For Pharmaceutical Sciences.
Mochel JP; Tyden E; Hellmann K; Vendrig JC; Şenel S; Dencker L; Cristina RT; Linden H; Schmerold I
J Vet Pharmacol Ther; 2018 Jun; 41(3):378-383. PubMed ID: 29266320
[TBL] [Abstract][Full Text] [Related]
3. New safe medicines faster: A proposal for a key action within the European union's 6th framework programme.
Bjerrum OJ
Pharmacol Toxicol; 2000; 86 Suppl 1():23-6. PubMed ID: 10905750
[TBL] [Abstract][Full Text] [Related]
4. Teaching science graduates to think business.
Bunk S
Nature; 2002 Jun; 417(6890):4-5. PubMed ID: 12066138
[No Abstract] [Full Text] [Related]
5. Does the European pharmaceutical industry have a future?
McKillop T
Circulation; 2006 Feb; 113(5):f19-20. PubMed ID: 16468149
[No Abstract] [Full Text] [Related]
6. Integrating systems approaches into pharmaceutical sciences.
Westerhoff HV; Mosekilde E; Noe CR; Clemensen AM
Eur J Pharm Sci; 2008 Sep; 35(1-2):1-4. PubMed ID: 18602464
[TBL] [Abstract][Full Text] [Related]
7. Getting the Dose Right: report from the Tenth European Federation of Pharmaceutical Sciences (EUFEPS) conference on optimizing drug development.
Stanski DR; Rowland M; Sheiner LB
J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):199-211. PubMed ID: 16283539
[TBL] [Abstract][Full Text] [Related]
8. Excellence in education and training advances competitiveness of the pharmaceutical industry in Europe.
Bjerrum OJ
Eur J Pharm Sci; 2011 Sep; 44(1-2):174-5. PubMed ID: 21782938
[TBL] [Abstract][Full Text] [Related]
9. Future European health care: cost containment, health care reform and scientific progress in drug research.
Emilien G
Int J Health Plann Manage; 1997; 12(2):81-101. PubMed ID: 10173136
[TBL] [Abstract][Full Text] [Related]
10. Getting into good company.
Hellemans A
Nature; 2002 Apr; 416(6883):5. PubMed ID: 11976631
[No Abstract] [Full Text] [Related]
11. Fewer jobs available for new PhDs.
Ann Neurol; 2012 Mar; 71(3):A8. PubMed ID: 22451215
[No Abstract] [Full Text] [Related]
12. The future of the pharmaceutical sciences and graduate education: recommendations from the AACP Graduate Education Special Interest Group.
Wu-Pong S; Gobburu J; O'Barr S; Shah K; Huber J; Weiner D;
Am J Pharm Educ; 2013 May; 77(4):S2. PubMed ID: 23716757
[TBL] [Abstract][Full Text] [Related]
13. [Future challenges and prospects for drug companies].
Lajoux C
Bull Acad Natl Med; 2008 Apr; 192(4):623-30; discussion 630-2. PubMed ID: 19024935
[TBL] [Abstract][Full Text] [Related]
14. Taking PAT to the next level.
Ciurczak EW; Ketolainen J; Laitinen R; Aaltonen J; Lindén HH
Eur J Pharm Sci; 2011 Jan; 42(1-2):1-2. PubMed ID: 21040783
[TBL] [Abstract][Full Text] [Related]
15. Challenges faced by the pharmaceutical industry: training graduates for employment in pharmaceutical R&D.
Mooney KG
Eur J Pharm Sci; 2001 Feb; 12(4):353-9. PubMed ID: 11231101
[TBL] [Abstract][Full Text] [Related]
16. [The influence of the pharmaceutical industry on treatment guidelines].
Smulders YM; Thijs A
Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2429-31. PubMed ID: 18064860
[TBL] [Abstract][Full Text] [Related]
17. Proposed guidelines for housestaff interaction with pharmaceutical companies.
Forrest DM; Ruedy J
Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
[TBL] [Abstract][Full Text] [Related]
18. The BREW workshop series: a stimulating experience in PhD education.
Giegerich R; Brazma A; Jonassen I; Ukkonen E; Vingron M
Brief Bioinform; 2008 May; 9(3):250-3. PubMed ID: 18216087
[TBL] [Abstract][Full Text] [Related]
19. [Pharmaceutical engineering in drug formulation].
Bruguera JL; Reynier JP; Rochat MH; Verain A
J Pharm Belg; 1990; 45(4):274-9. PubMed ID: 2290123
[TBL] [Abstract][Full Text] [Related]
20. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
Razack S; Arbour L; Hutcheon R
Ann R Coll Physicians Surg Can; 1999 Mar; 32(2):93-6. PubMed ID: 12378718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
